How to balance the risk of missing a cancerous tumor with the risk of treating — at substantial human cost — when treatment may be unnecessary or futile? The new Canadian study of mammography, published Tuesday in BMJ, sharpens this question once again. Most of us who’ve been around a while know people, some […]
Continue reading →Note: This review first appeared in Nature, 2 May 2012. My thanks to Nature for the commission and fine editorial support. When it is published later this month, the fifth edition of the American Psychiatric Association’s Diagnostic and Statistical Manual, DSM-5, will mark well over a century of formal guides to psychiatric diagnosis. The first two psychiatric […]
Continue reading →Below find #4 in my Best of Neuron Culture Moving Party — a run of 10 of my favorite posts from the blog’s tenure at WIRED, posted as I moved the blog here. This post, “The PTSD Trap,” is a substantially longer version — call it the director’s cut — of a feature I published […]
Continue reading →Over at Slate I have a story, “The New Temper Tantrum Disorder,” about the “Disruptive Mood Dysregulation Disorder” I wrote about more briefly here a couple weeks ago, when DMDD was still a proposed diagnosis. Last week the DMDD diagnosis was approved for inclusion in the American Psychiatric Association’s forthcoming Diagnostic Statistical Manual, Fifth Edition — […]
Continue reading →Every decade or two, the American Psychiatric Association reworks its Diagnostic Statistical Manual, or DSM, to try to have diagnostic categories reflect the current state of theory and practice. Given enormous evidence that we’re currently overdiagnosing things and medicalizing normal behavior, many had hope that the upcoming DMS-5 — the fifth major revision — would show some restraint. Instead it seems that the DSM-5 may include a new proposed “mood disorder” called “disruptive mood dysregulation disorder,” or DMDD.
Continue reading →